A trial found Vytorin cut cardiovascular events in chronic kidney disease patients by 17 percent against placebo, which critics say does not show Zetia adds to simvastatin. An Italian trial in diabetic heart patients found Vytorin 10/20 cut LDL 32.2 percent against 20.8 for simvastatin 40 mg.
Section archive
Myocardial Infarction
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Supplements
Omega-3 fatty acids don't cut risk of heart disease?
In 4,837 heart attack survivors aged 60 to 80, low doses of EPA and DHA or of ALA did not cut major cardiovascular events, researchers reported at the 2010 European Society of Cardiology Congress. Many variables were in play, so the trial does not settle the question.
Minerals
Calcium supplements versus myocardial infarction: What you need to know
University of Auckland researchers pooled more than a dozen trials and epidemiological studies covering 11,921 participants followed about four years, and found people taking calcium supplements were 30 percent more likely to suffer a heart attack. None of them took vitamin D alongside the calcium.
4 stories